Intermittent Intravenous Insulin Therapy
Customize your policy alerts
Sign up for Aetna Policy 0742 alerts
Get alerted when Policy 0742 changes without checking for updates manually.
Monitor payer policy activity
This policy governs the coverage and clinical assessment of intermittent (pulsatile) intravenous insulin therapy, including variants such as hepatic activation therapy, metabolic activation therapy, pulsatile intravenous insulin therapy (PIVIT), and Trina Health artificial pancreas treatment; it affects members for whom these therapies are proposed and providers seeking reimbursement from Aetna.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.